A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.

NCT04398251 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hypouricemia, Renal
Urolithiasis

Interventions

DRUG: Febuxostat 40mg Tab
BEHAVIORAL: Non-drug control group

Sponsor

Xuhui Central Hospital, Shanghai